The presence of germline mutations in DNA repair genes, such as MLH1, MSH2, and BRCA2, underscores the importance of genetic testing for hereditary cancer syndromes like Lynch syndrome and Cowden syndrome in patients diagnosed with endometrial cancer. This evidence concerns the gene MLH1 and Lynch syndrome.